COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,357 Articles (22,803 medRxiv, 8,554 bioRxiv)

Most recent first Previous |  Page 1730: Articles 17291-17300  | Next

Optimal vaccination strategies for COVID-19 based on dynamical social networks with real-time updating
Cheng, S., Arcucci, R., Pain, C., Guo, Y.
10.1101/2021.03.11.21253356 — Posted: 2021-03-12 Discussion: Onsite
Analysis of Accumulated SARS-CoV-2 Seroconversion in North Carolina: The COVID-19 Community Research Partnership
Williamson, J. C., Wierzba, T. F., Santacatterina, M., Munawar, I., Seals, A. L., Pittman Ballard, C. A., Alexander-Miller, M., Runyon, M. S., McCurdy, L. H., Gibbs, M. A., Ahmed, A., Lagarde, W. H., Maguire, P. D., King-Thiele, R., Hamrick, T., Ihmeidan, A., Henderson, S., Uschner, D., Herrington, D. M., Sanders, J. W.
10.1101/2021.03.11.21253226 — Posted: 2021-03-12
Reducing the Cost of Rapid Antigen Tests through Swab Pooling and Extraction in a Device
Berking, T., Lorenz, S. G., Ulrich, A., Greiner, J., Richert, C.
10.1101/2021.03.11.21252969 — Posted: 2021-03-12
Are vaccines safe in patients with Long COVID? A prospective observational study.
Arnold, D. T., Milne, A., Stadon, L., Maskell, N. A., Hamilton, F. W.
10.1101/2021.03.11.21253225 — Posted: 2021-03-12 Discussion: Onsite | Offsite
Risk, clinical course and outcome of ischemic stroke in patients hospitalized with COVID-19: a multicenter cohort study
Sluis, W. M., Linschoten, M., Biesbroek, J. M., den Hertog, H. M., Ribbers, T., Nieuwkamp, D., van Houwelingen, R. C., Dias, A., van Uden, I. W., Kerklaan, J. P., Bienfait, H. P., Vermeer, S. E., de Jong, S. W., Ali, M., Wermer, M. J., de Graaf, M. T., Brouwers, P. J., Asselbergs, F. W., Kappelle, L. J., van der Worp, H. B., Algra, A. M., CAPACITY-COVID collaborative consortium
10.1101/2021.03.11.21253189 — Posted: 2021-03-12
Acceptance and intake of COVID-19 vaccines among older Germans
Malesza, M., Wittmann, E.
10.1101/2021.03.10.21253346 — Posted: 2021-03-12
A tale of three SARS-CoV-2 variants with independently acquired P681H mutations in New York State
Lasek-Nesselquist, E., Pata, J., Schneider, E., St. George, K.
10.1101/2021.03.10.21253285 — Posted: 2021-03-12
SARS-CoV-2 Serology Status Detected by Commercialized Platforms Distinguishes Previous Infection and Vaccination Adaptive Immune Responses
Suhandynata, R. T., Bevins, N. J., Tran, J. T., Huang, D., Hoffman, M. A., Lund, K., Kelner, M. J., McLawhon, R. W., Gonias, S. L., Nemazee, D., Fitzgerald, R. L.
10.1101/2021.03.10.21253299 — Posted: 2021-03-12
Specific allelic discrimination of N501Y and other SARS-CoV-2 mutations by ddPCR detects B.1.1.7 lineage in Washington State
Perchetti, G. A., Zhu, H., Mills, M. G., Shrestha, L., Wagner, C., Bakhash, S. M., Lin, M. J., Xie, H., Huang, M., Mathias, P. C., Bedford, T., Jerome, K., Greninger, A. L., Roychoudhury, P.
10.1101/2021.03.10.21253321 — Posted: 2021-03-12
Type I, II, and III interferon signatures correspond to COVID-19 disease severity
Kim, M.-H., Salloum, S., Wang, J. Y., Wong, L. P., Regan, J., Lefteri, K., Manickas-Hill, Z., Sadreyev, R., Li, J. Z., Yu, X., Chung, R.
10.1101/2021.03.10.21253317 — Posted: 2021-03-12

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).